63 results
8-K
CGTX
Cognition Therapeutics Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:07pm
, 2024, subject to the satisfaction of customary closing conditions.
The Shares will be issued pursuant to a Registration Statement on Form S-3 (File
8-K
EX-1.1
CGTX
Cognition Therapeutics Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:07pm
and the Company shall deliver the other items required pursuant to Section 2.3 deliverable at the Closing. Upon satisfaction of the covenants … in the Registration Statement or the Prospectus or otherwise) shall have been complied with to the satisfaction of the Commission and the Underwriter
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
to stockholders after the payment of all of our debts and other liabilities, subject to the satisfaction of any liquidation preference granted
424B5
CGTX
Cognition Therapeutics Inc
11 Mar 24
Prospectus supplement for primary offering
4:06pm
of all of our debts and other liabilities, subject to the satisfaction of any liquidation preference granted to the holders of any then outstanding
8-K
EX-10.1
fx83ilv8n5j0z
20 Feb 24
Departure of Directors or Certain Officers
4:44pm
424B4
4yl6wdxp9jfmcjsf99b
8 Jan 24
Prospectus supplement with pricing info
4:11pm
8-K
EX-10.1
3xnqpi
23 Dec 22
Entry into a Material Definitive Agreement
4:24pm
S-3
EX-4.4
7jc ywaemy00om
23 Dec 22
Shelf registration
4:16pm
S-3
x0srogu5 0l6m4zlqnga
23 Dec 22
Shelf registration
4:16pm
S-3
EX-1.2
eejkscngmg 4nifufdl
23 Dec 22
Shelf registration
4:16pm
8-K
EX-99.2
83dj 2mh07fv8q1o
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
8-K
EX-1.1
kidchiv9q 2f
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
424B4
bjtx0z856xl7e4
14 Nov 22
Prospectus supplement with pricing info
6:02am